Management of Perianal Candidiasis in the Setting of Fecal Incontinence

First‑Line Topical Antifungal Therapy

Topical azole antifungals (e.g., clotrimazole or miconazole) applied 2–3 times daily constitute the first‑line treatment for perianal candidiasis, and current evidence does not demonstrate a clear superiority of one azole over another. 1

The presence of satellite lesions, beefy‑red erythema with white plaques, and maceration of the perianal skin are considered classic clinical signs that confirm candidal involvement. [1][2]

Oral fluconazole (100–200 mg daily for 7–14 days) should be considered when the infection extends beyond the perianal region to adjacent areas such as the inguinal folds or buttocks. [1][2]
Systemic therapy is advised if there is no clinical response to an adequate course of topical antifungal treatment after 7–10 days. 1
Immunocompromised individuals with severe perianal candidiasis are candidates for oral fluconazole as part of the treatment regimen. 2

The Infectious Diseases Society of America guidelines recommend applying topical antifungal agents, such as azoles (clotrimazole, miconazole) and polyenes (nystatin), directly to the perianal area 2-3 times daily until complete healing occurs in children with perianal candidiasis 3
Topical azole antifungals (clotrimazole or miconazole) or nystatin cream applied 2-3 times daily to the affected area are the recommended first-line treatments for perianal candidiasis in children 3

Keeping the perianal area dry is essential for treatment success, as moisture control is critical for managing candidal skin infections, according to the IDSA guidelines 3

Systemic antifungals should not be used as first-line therapy for uncomplicated perianal candidiasis, as topical agents are highly effective and avoid unnecessary systemic exposure, according to the Infectious Diseases Society of America guidelines 3